Felicita Corzani
Papers
1
Total Citations
15
H-Index
1
About
Dr. Felicita Corzani is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly robotic-assisted lobectomy. Her landmark 2022 study, "Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer," has garnered 15 citations and represents a critical contribution to the evolving paradigm of lung cancer surgery. In this work, Dr. Corzani systematically evaluated the efficacy of robotic surgery compared to traditional thoracotomy, demonstrating that robotic approaches can achieve comparable oncological outcomes while significantly improving peri-operative recovery for patients. Her research addresses a pivotal question in thoracic oncology: whether the technological advantages of robotic platforms translate into meaningful clinical benefits without compromising cancer control. By providing robust evidence on lymph node dissection completeness and long-term survival rates, Dr. Corzani has helped validate robotic lobectomy as a standard option for early-stage disease. Her work bridges the gap between surgical innovation and evidence-based practice, offering surgeons and patients alike a compelling alternative to conventional approaches. Through her rigorous methodology and patient-centered outcomes analysis, Dr. Corzani continues to shape the future of lung cancer surgery, making her a respected voice in the field of robotic thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1